Irune
Ruiz Díaz
King's College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de King's College London (1)
2019
-
Vemurafenib as first-line therapy in BRAF -V600E-mutant Erdheim-Chester disease with CNS involvement
BMJ Case Reports, Vol. 12, Núm. 11